Menu
Enrolling by invitation NCT06507137

Fractal-based Gait Training in Older Adults

No phase Interventional Healthy Aging

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Fractal, Isochronous, Control.
Who it may be relevant to
Registry conditions: Healthy Aging. Basic parameters: 60 years — 100 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Portugal
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Fractal-based Gait Training in Older Adults: Implications to Motor Control and Neuroplasticity

Overview

The purpose of the study is to investigate the influence of walking with external visual cues on brain adaptations.

Interventions

  • Other Fractal
    Walking in a treadmill while synchronizing their steps with fractal external visual cues
  • Other Isochronous
    Walking in a treadmill while synchronizing their steps with isochronous external visual cues
  • Other Control
    Walking in a treadmill

Primary outcome measures

  • Fractal scaling exponent (α) changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups. [Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)]
Secondary outcome measures (10)
  • Corticospinal excitability (CSE) changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups. [Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)]
  • Short-Interval Intracortical Inhibition (SICI) changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups. [Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)]
  • Intracortical Facilitation (ICF) changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups. [Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)]
  • Ankle, Knee and Hip joints range of motion's changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups during a gait cycle [Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)]
  • Ankle, Knee and Hip joints maximum value changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups during a gait cycle [Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)]
  • Ankle, Knee and Hip joints minimum value changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups during a gait cycle [Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)]
  • Ankle, Knee and Hip joints angles during initial contact changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups during a gait cycle [Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)]
  • Ankle, Knee and Hip joints angles during peak ground reaction force changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups during a gait cycle [Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)]
  • Coefficient of variation (CV) changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups. [Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)]
  • Electromyography co-contraction changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups. [Time frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)]

Eligibility criteria

Exclusion criteria

  • Neurologic conditions;
  • Lower limb disabilities or disease;
  • Not able to provide informed consent;
  • Unable to walk unassisted for 10-minutes continuously;
  • Score below 24 in the Mini-Mental State Examination (MMSE);
  • Have a history of falls in the prior six months;
  • Have an implanted device (e.g., pacemakers);
  • Medication advised against the application of Transcranial Magnetic Stimulation.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Basic science

Study locations

Portugal · 1 center
  • Egas Moniz School of Health and Science — Almada

Identifiers

NCT: NCT06507137 · FRACTRAIN-1378/24

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗